Nath Bio-Genes (India) profit and loss

Latest FY26

Revenue: ₹445cr+22.0% on FY25
EBITDA: ₹52.4cr+5.3% on FY25
Net profit: ₹41.6cr+7.9% on FY25
EPS: ₹20.98+4.2% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	490	445	365	333	301	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	7.9	7.8	4.5	0.6	0.6
	498	453	369	333	302
	312	306	226	142	117
	4.6	7.7	12.7	12.3	5.3
	−89.9	−112	−103	−21.2	12.0
	37.0	35.8	32.5	28.3	23.3
	17.1	16.0	10.5	9.1	10.1
	4.0	4.0	3.8	3.3	3.0
	177	155	147	121	94.7
	462	413	329	295	266
	49.3	52.4	49.8	49.9	48.7
	45.3	48.5	46.0	46.6	45.7
Profit
	36.2	40.3	40.0	38.1	36.2
	7.2	6.0	0.5	3.4	0.0
	43.4	46.3	40.6	41.6	36.2
	4.6	4.5	2.0	1.9	1.2
	0.2	0.2	−0.1	0.0	−0.0
	4.7	4.7	2.0	1.9	1.2
	−2.1	0.0	0.0	0.0	0.0
	36.6	41.6	38.6	39.6	35.0
	38.7	41.6	38.6	39.6	35.0
	−1.5	−1.8	−0.3	0.9	0.0
	35.1	39.9	38.3	40.5	35.0
	—	—	38.6	39.6	—
Per share
	₹18.43	₹20.98	₹20.14	₹21.34	₹18.42
	₹18.43	₹20.98	₹20.14	₹21.34	₹18.42
Other comprehensive income — detail
	−1.5	−1.8	−0.3	—	—
	1.8	1.9	0.1	—	—
	—	—	—	0.1	−0.0
	−0.3	−0.1	0.3	—	—
	—	—	—	−1.0	0.0
	—	—	38.6	39.6	—
Per share — as-filed variants
	₹18.43	₹20.98	₹0.00	₹21.34	₹18.42
	₹18.43	₹20.98	₹0.00	₹21.34	₹18.42
	₹0.00	₹0.00	₹20.14	₹0.00	₹0.00
	₹0.00	₹0.00	₹20.14	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	263	244	229	199	167
	53.8%	54.7%	62.9%	59.8%	55.3%
Adjusted (ex-exceptional items) — derived
	36.2	40.3	40.0	38.1	36.2
	7.2	6.0	0.5	3.4	0.0
	30.2	36.2	38.1	36.3	35.0
	₹15.20	₹18.26	₹19.87	₹19.57	₹18.42

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATHBIOGEN₹131.40

Nath Bio-Genes (India) Limited

· FMCG & Retail

Annual Quarterly₹ CrorePeersSARVESHWAR INDOUS SUKHJITS KOHINOOR AGRITECH REGAAL BSHSL GULPOLYMcap ₹250 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	301.4	332.6	364.9	445.1	489.8
Other Income	0.6	0.6	4.5	7.8	7.9
Total Income	301.9	333.3	369.5	452.9	497.8
Expenses
+ Cost of Materials Consumed	117.3	142.5	225.5	306.2	311.8
+ Purchases of Stock-in-Trade	5.3	12.3	12.7	7.7	4.6
+ Changes in Inventories	12.0	-21.2	-102.7	-112.4	-89.9
+ Employee Benefit Expense	23.3	28.3	32.5	35.8	37.0
+ Finance Costs	10.1	9.1	10.5	16.0	17.1
+ Depreciation & Amortisation	3.0	3.3	3.8	4.0	4.0
+ Other Expenses	94.7	120.9	147.1	155.4	177.0
Total Expenses	265.8	295.1	329.4	412.6	461.6
EBITDA	48.7	49.9	49.8	52.4	49.3
EBIT	45.7	46.6	46.0	48.5	45.3
Profit
PBT before Exceptional Items	36.2	38.1	40.0	40.3	36.2
+ Exceptional Items	0.0	3.4	0.5	6.0	7.2
Pretax Income	36.2	41.6	40.6	46.3	43.4
+ Current Tax	1.2	1.9	2.0	4.5	4.6
+ Deferred Tax	-0.0	0.0	-0.1	0.2	0.2
Tax Expense	1.2	1.9	2.0	4.7	4.7
+ Share of Associates & JVs	0.0	0.0	0.0	0.0	-2.1
Net Income	35.0	39.6	38.6	41.6	36.6
+ Net Income — Continuing Ops	35.0	39.6	38.6	41.6	38.7
+ Other Comprehensive Income	0.0	0.9	-0.3	-1.8	-1.5
Total Comprehensive Income	35.0	40.5	38.3	39.9	35.1
Net Income to Common	—	39.6	38.6	—	—
Per Share
Basic EPS	18.42	21.34	20.14	20.98	18.43
Diluted EPS	18.42	21.34	20.14	20.98	18.43
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.3	-1.8	-1.5
+ Tax on Items NOT to be Reclassified	—	—	0.1	1.9	1.8
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	0.1	—	—	—
+ Tax on Items to be Reclassified	—	—	0.3	-0.1	-0.3
+ Tax on Items to be Reclassified — alt tag	0.0	-1.0	—	—	—
Comprehensive Income — Owners of Parent	—	39.6	38.6	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	18.42	21.34	0.00	20.98	18.43
Diluted EPS — Continuing Operations	18.42	21.34	0.00	20.98	18.43
Basic EPS — Discontinued Operations	0.00	0.00	20.14	0.00	0.00
Diluted EPS — Discontinued Operations	0.00	0.00	20.14	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	166.8	199.1	229.4	243.6	263.3
Gross Margin %	55.33	59.84	62.85	54.73	53.76
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	36.2	38.1	40.0	40.3	36.2
− Exceptional Items (reconciliation)	0.0	3.4	0.5	6.0	7.2
Net Income Adj (tax-effected)	35.0	36.3	38.1	36.2	30.2
EPS Adj	18.42	19.57	19.87	18.26	15.20
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	19.0	19.0	19.0	19.0	19.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.